![](/img/cover-not-exists.png)
P2-222: Can the patients with locally advanced non-small cell lung cancer (LANSCLC) tolerate 60mg/m2 docetaxel on day 1 and 30mg/m2 Cisplatin on day 1 and 2 for 2 cycles during concurrent radiotherapy (CCRT) after 2-3 cycles of induction chemotherapy?
Yu, Rong, Zhu, Guangying, Shi, AnhuiVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283930.30872.6b
Date:
August, 2007
File:
PDF, 314 KB
english, 2007